Brand New Energy ("BNE"), dietary supplement re-sale distributor, is recalling all lot codes of EphBurn 25. The recall was initiated on August 28, 2012, after notification by the Food and Drug Administration (FDA) to a third-party retailer which purchased EphBurn 25 that one lot of EphBurn 25 was sampled by the FDA and found to contain ephedrine alkaloids, making it an unapproved drug.
FDA approves Linzess to treat certain cases of irritable bowel syndrome and constipation
The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.
FDA approves new treatment for severe neutropenia in certain cancer patients
The U.S. Food and Drug Administration today approved Sicor Biotech’s tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.
Spokane Produce Inc., Voluntarily Recalls Pineapple/Mango Pico de Gallo Product Because of Possible Health Risk
Spokane Produce, Inc., is voluntarily recalling a small lot run of Pineapple/Mango Pico de Gallo beca use it has the potential to be contaminated with Salmonella braenderup. Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Splendid Products Voluntarily Recalls Daniella Brand Mangoes Because Of Possible Health Risk
Produce distributor Splendid Products is voluntarily recalling certain lots of Daniella brand mangoes because they may be contaminated with Salmonella. The recalled mangoes, a product of Mexico, were sold as individual fruit and can be identified by the Daniella brand sticker and one of the following PLU numbers: 3114, 4051, 4311, 4584 or 4959.
Read The Complete Story!
FDA approves first drug formulated for children with rare brain tumor
The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma (SEGA). Afinitor Disperz is the first approved pediatric-specific dosage form developed for the treatment of a pediatric tumor.
Giant Food Alerts Customers to Voluntary Recall of Splendid Products LLC Daniella Mangos
Giant Food of Landover, Md., following a voluntary recall by Splendid Products, announced it removed from sale Daniella mangos due to possible salmonella contamination.
Samantha Lynn Inc. Is Voluntary Recalling of all lots of Reumofan Plus Tablets Due to Undeclared Drug Ingredients
August 24, 2012, Los Angeles, CA. Samantha Lynn Inc. is voluntarily recalling Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients. The Food and Drug Administration (FDA) sample analysis has found the product to contain methocarbamol, dexamethasone, and diclofenac.
FDA approves new combination pill for HIV treatment for some patients
The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.
Samantha Lynn Inc. Issues Voluntary Nationwide Recall of Reumofan Plus Tablets Due to Undeclared Drug Ingredients
Samantha Lynn Inc. is voluntarily recalling 500 lots of Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients. The Food and Drug Administration (FDA) sample analysis has found the product to contain methocarbamol and diclofenac.